"This is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.---Winston Churchill [@bib1]"

*JACC: Basic to Translational Science* was launched in February 2015, with a journalistic vision of providing a literary home for those committed to developing new therapies to improve the outcomes of patients afflicted with cardiovascular disease. Over the ensuing 4 years, the journal has sought to publish papers that have a clear translational vector, which the Editorial Board defines as any research that will lead to the development of new therapy. I am excited to announce that beginning with the August issue, *JACC: Basic to Translational Science* will be published monthly. Given that *JACC: Basic to Translational Science* is an open access journal, authors will now be able to have their work disseminated worldwide, within months of the final acceptance of their manuscript.

As Editor-in-Chief, I recognize that journals do not exist in a vacuum, and that any journalistic undertaking takes a village. Accordingly, I would like to acknowledge a number of individuals who have been critical to the journey thus far. First and foremost, I would like to thank the Editorial Board for their commitment to the mission of the journal: Kristen Newby (Deputy Editor), Brian Annex, Nanette Bishopric, Dan Kelly, Juan Granada (Guest Editor), Peter Libby (who coined the term translational vector), W. Robb MacLellan, Geoff Pitt, Robert Roberts (Guest Editor-in-Chief), Eva van Rooij; our woke social media editors, Meena Mathur and Reza Ardehali; Cindy Green, our statistical editor; and Amanda Coniglio, Michelle Kelsey, and Vishal Rao, our talented CME Editors. A very special shout out to Kim Trevey (Managing Editor) for keeping everyone (especially me) organized and on time. I would be remiss if I did not acknowledge the support of our Editorial Consultants (<http://basictranslational.onlinejacc.org/content/editorial-board>) and the amazing reviewers who have provided fair and balanced reviews in a timely manner. Last, I would like to thank the authors who have entrusted their life's work to a new journal, as well as the awesome readership of *JACC: Basic to Translational Science,* without whose enthusiastic support we would not exist.

Going forward, we are committed to improving the timeliness of our review process, as well as expanding the content of the journal by soliciting targeted reviews and commentaries on topics that are relevant to the field of cardiovascular translational medicine, in order to fulfill our mandate to become *the* forum and learning center for translational cardiovascular investigators in academia and industry, patients and families impacted by heart disease, the National Heart, Lung, and Blood Institute, and the U.S. Food and Drug Administration. As always, we welcome your thoughts about ways we can improve the journal and the kind of content you would like to read in the journal, either through social media (*\#JACC:BTS*) or by email (<jaccbts@acc.org>).
